Physician profile
Jenna M Risley
NPI 1992277511
$5,276.96
in general payments reported to CMS, 2019-2025
30 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $917 · 2022: $1,222 · 2023: $1,596 · 2024: $1,041 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,138.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $978.01 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $971.71 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $508.61 | 2022-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $360.12 | 2021-2024 | Myrbetriq, Xtandi, Veozah |
| Urovant Sciences INC | $309.63 | 2021-2022 | |
| Pfizer INC. | $288.00 | 2021-2025 | |
| Allergan, INC. | $232.09 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $216.40 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Dendreon Pharmaceuticals LLC | $213.82 | 2021 | |
| Endo Pharmaceuticals INC. | $148.66 | 2021-2024 | Xiaflex, Aveed |
| Antares Pharma, INC. | $128.92 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Olympus America INC. | $127.64 | 2022-2025 | Itind System |
| Progenics Pharmaceuticals, INC. | $113.99 | 2022-2024 | Pylarify |
| Myovant Sciences INC. | $111.28 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $88.35 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $86.66 | 2021-2022 | |
| Halozyme INC | $66.50 | 2023 | |
| 180 Medical, INC. | $57.91 | 2021 | |
| Axonics, INC. | $45.56 | 2022-2023 | Axonics |
| Coloplast Corp | $39.30 | 2023-2024 | Vortek Hydro |
| Urogen Pharma, INC. | $27.36 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $21.93 | 2022 | |
| Tolmar, INC. | $19.94 | 2024 | |
| Medtronic, INC. | $19.38 | 2021 | |
| Procept Biorobotics Corporation | $17.94 | 2023 | Aquabeam Robotic System |
| Ferring Pharmaceuticals INC. | $17.22 | 2024 | Adstiladrin |
| Blue Earth Diagnostics | $16.10 | 2023 | |
| Boston Scientific Corporation | $15.34 | 2021 | |
| Travere Therapeutics, INC. | $15.02 | 2021 | |
| Mission Pharmacal Company | $13.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Risley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.